Rafaela Cachiolo Antunes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rafaela Cachiolo Antunes has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ana Chrystina de Souza Crippa
Universidade Federal do Paraná, Hospital das Clínicas, Unidade de Neuropediatria, Curitiba PR, Brazil
2 shared publications - Mariana Aparecida Pasa Morgan
Faculdade Ceres
2 shared publications - Priscila Vernizi Roth
Division of Pediatric Dermatology, Department of Pediatrics Complexo Hospital de Clínicas of Federal University of Parana, UFPR Curitiba Brazil
2 shared publications - Renata Drizlionoks
Federal University of Parana, Curitiba, Brazil
2 shared publications - Vânia Oliveira Carvalho
Pediatric Dermatology Division, Department of Pediatrics, Federal University of Paraná, UFPR, Curitiba, Brazil
2 shared publications - Enzo Paolo Brandão Gouveia
Department of Pediatrics - Division of Pediatric Dermatology, Federal University of Paraná, Curitiba, Paraná, Brazil
1 shared publication
Latest Publications
- 18 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Frequency of sleep disturbances and signs of attention deficit and hyperactivity disorder in schoolchildren with atopic dermatitis
- 18 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Frequency of sleep disturbances and signs of attention deficit and hyperactivity disorder in schoolchildren with atopic dermatitis
- Open Access
- 29 May 2024
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (01) , e97-e103
Atopic Dermatitis, Sleep, and the COVID-19 Pandemic
Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd (p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.
- 29 May 2024
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (01) , e97-e103
Open AccessAtopic Dermatitis, Sleep, and the COVID-19 Pandemic
Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd (p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.